Literature DB >> 2688639

Long-term maintenance of high rates of very-low-density-lipoprotein secretion in hepatocyte cultures. A model for studying the direct effects of insulin and insulin deficiency in vitro.

J M Duerden1, S M Bartlett, G F Gibbons.   

Abstract

High rates of hepatic cellular triacylglycerol synthesis and very-low-density-lipoprotein (VLDL) triacylglycerol output were maintained in vitro for at least 3 days when hepatocytes were cultured in a medium lacking insulin but supplemented with 1 microM-dexamethasone, 10 mM-lactate, 1 mM-pyruvate and 0.75 mM-oleate (supplemented medium). Under these conditions VLDL output remained constant, whereas cell triacyglycerol content increased 10-fold over 3 days, suggesting that the secretory process was saturated. Insulin, present during the first 24 h period, enhanced the storage of cellular triacylglycerol by inhibiting the secretion of VLDL. This stored triacyglycerol was subsequently released into the medium as VLDL if insulin was removed. With the supplemented medium the increased rate of VLDL secretion after insulin removal exceeded that observed under 'saturating' conditions, suggesting that pre-treatment with insulin enhanced the capacity for VLDL secretion. In contrast with the short-term (24 h) effects of insulin, longer-term exposure (greater than 48 h) to insulin enhanced the secretion of VLDL compared with insulin-untreated cultures. Under these conditions, insulin increased the net rates of triacylglycerol synthesis. The results suggest that insulin affects the secretion of VLDL triacylglycerol by two distinct and opposing mechanisms: first, by direct inhibition of secretion; second by increasing triacylglycerol synthesis, which stimulates secretion. The net effect at any time depends upon the relative importance of each of these processes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2688639      PMCID: PMC1133520          DOI: 10.1042/bj2630937

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

1.  Relationship between activity of hepatic 3-hydroxy-3-methylglutaryl-coenzyme A reductase and secretion of very-low-density-lipoprotein cholesterol by the isolated perfused liver and in the intact rat.

Authors:  E H Goh; M Heimberg
Journal:  Biochem J       Date:  1979-10-15       Impact factor: 3.857

2.  Reappraisal of the role of insulin in hypertriglyceridemia.

Authors:  J M Olefsky; J W Farquhar; G M Reaven
Journal:  Am J Med       Date:  1974-10       Impact factor: 4.965

3.  Effect of a single insulin administration on the hepatic release of triglycerides into the plasma.

Authors:  L G Alcindor; R Infante; C Soler-Argilaga; J Polonovski
Journal:  Biochim Biophys Acta       Date:  1973-06-21

4.  Hepatic lipid metabolism in experimental diabetes. V. The effect of concentration of oleate on metabolism of triglycerides and on ketogenesis.

Authors:  D R Van Harken; C W Dixon; M Heimberg
Journal:  J Biol Chem       Date:  1969-05-10       Impact factor: 5.157

5.  Effects of anti-insulin serum, insulin, and glucose on output of triglycerides and on ketogenesis by the perfused rat liver.

Authors:  W F Woodside; M Heimberg
Journal:  J Biol Chem       Date:  1976-01-10       Impact factor: 5.157

6.  Effects of insulin on lipoprotein secretion in rat hepatocyte cultures. The role of the insulin receptor.

Authors:  W Patsch; A M Gotto; J R Patsch
Journal:  J Biol Chem       Date:  1986-07-25       Impact factor: 5.157

7.  Hepatic production of VLDL-triglycerides. Dependence of portal substrate and insulin concentration.

Authors:  K H Vogelberg; F A Gries; D Moschinski
Journal:  Horm Metab Res       Date:  1980-12       Impact factor: 2.936

8.  Lipoprotein secretion by isolated perfused livers from streptozotocin-diabetic rats.

Authors:  E M Berry; E Ziv; H Bar-On
Journal:  Diabetologia       Date:  1981-10       Impact factor: 10.122

9.  Diabetic hypertriglyceridemia: evidence for three clinical syndromes.

Authors:  G M Reaven; M S Greenfield
Journal:  Diabetes       Date:  1981       Impact factor: 9.461

10.  Evidence for multiple causality in the development of diabetic hypertriglyceridaemia.

Authors:  D Weiland; C E Mondon; G M Reaven
Journal:  Diabetologia       Date:  1980-04       Impact factor: 10.122

View more
  25 in total

Review 1.  The roles of insulin and fatty acids in the regulation of hepatic very-low-density lipoprotein assembly.

Authors:  G F Gibbons; A M Brown; D Wiggins; R Pease
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

2.  Storage, mobilization and secretion of cytosolic triacylglycerol in hepatocyte cultures. The role of insulin.

Authors:  J M Duerden; G F Gibbons
Journal:  Biochem J       Date:  1990-12-15       Impact factor: 3.857

3.  Contributions of de novo synthesis of fatty acids to total VLDL-triglyceride secretion during prolonged hyperglycemia/hyperinsulinemia in normal man.

Authors:  A Aarsland; D Chinkes; R R Wolfe
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

4.  The lipolysis/esterification cycle of hepatic triacylglycerol. Its role in the secretion of very-low-density lipoprotein and its response to hormones and sulphonylureas.

Authors:  D Wiggins; G F Gibbons
Journal:  Biochem J       Date:  1992-06-01       Impact factor: 3.857

Review 5.  Role of insulin in hepatic fatty acid partitioning: emerging concepts.

Authors:  V A Zammit
Journal:  Biochem J       Date:  1996-02-15       Impact factor: 3.857

6.  Interaction of non-esterified fatty acid and insulin in control of triacylglycerol secretion by Hep G2 cells.

Authors:  C D Byrne; N P Brindle; T W Wang; C N Hales
Journal:  Biochem J       Date:  1991-11-15       Impact factor: 3.857

7.  Decreased secretion of very-low-density lipoprotein triacylglycerol and apolipoprotein B is associated with decreased intracellular triacylglycerol lipolysis in hepatocytes derived from rats fed orotic acid or n-3 fatty acids.

Authors:  A M Hebbachi; M C Seelaender; B W Baker; G F Gibbons
Journal:  Biochem J       Date:  1997-08-01       Impact factor: 3.857

8.  The intracellular triacylglycerol/fatty acid cycle: a comparison of its activity in hepatocytes which secrete exclusively apolipoprotein (apo) B100 very-low-density lipoprotein (VLDL) and in those which secrete predominantly apoB48 VLDL.

Authors:  A M Salter; D Wiggins; V A Sessions; G F Gibbons
Journal:  Biochem J       Date:  1998-06-15       Impact factor: 3.857

9.  Restoration in vitro of normal rates of very-low-density lipoprotein triacylglycerol and apoprotein B secretion in hepatocyte cultures from diabetic rats.

Authors:  J M Duerden; G F Gibbons
Journal:  Biochem J       Date:  1993-08-15       Impact factor: 3.857

10.  Effects of insulin treatment of diabetic rats on hepatic partitioning of fatty acids between oxidation and esterification, phospholipid and acylglycerol synthesis, and on the fractional rate of secretion of triacylglycerol in vivo.

Authors:  A M Moir; V A Zammit
Journal:  Biochem J       Date:  1994-11-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.